HADHA Gene Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency Genetic Test
At DNA Labs UAE, we offer the HADHA Gene Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency Genetic Test at a cost of AED 4400.0. This test is used to diagnose individuals with suspected LCHAD deficiency, a rare autosomal recessive disorder.
Test Details
The HADHA gene is responsible for encoding the long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) enzyme. Deficiency in this enzyme is known as LCHAD deficiency. Our NGS (Next-Generation Sequencing) Genetic Test uses high-throughput sequencing methods to analyze multiple genes simultaneously.
This test can identify mutations or variations in the HADHA gene that may be responsible for LCHAD deficiency. It can also be used to identify carriers of the condition and for prenatal testing in families with a history of LCHAD deficiency to determine if the fetus is affected.
Compared to traditional sequencing methods, NGS genetic testing provides a more comprehensive and efficient approach as it allows for the analysis of multiple genes simultaneously. This can help in identifying other genetic variations or mutations that may contribute to the development of LCHAD deficiency or other related conditions.
Test Components and Price
Test Name: HADHA Gene Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency Genetic Test
Components: NGS Technology
Price: AED 4400.0
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information
Before undergoing the HADHA Gene Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Genetic counseling is an essential step in understanding the inheritance pattern and risk factors associated with LCHAD deficiency. It can provide valuable information for individuals and families affected by this disorder.
For more information or to schedule an appointment for the HADHA Gene Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency Genetic Test, please contact DNA Labs UAE.
| Test Name | HADHA Gene Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for HADHA Gene Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| Test Details |
The HADHA gene is responsible for encoding the long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) enzyme. Deficiency in this enzyme is known as LCHAD deficiency, which is a rare autosomal recessive disorder. NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses high-throughput sequencing methods to analyze multiple genes simultaneously. In the context of LCHAD deficiency, an NGS genetic test can be used to identify mutations or variations in the HADHA gene that may be responsible for the disorder. This type of genetic testing can help in diagnosing individuals with suspected LCHAD deficiency, as well as identifying carriers of the condition. It can also be used for prenatal testing in families with a history of LCHAD deficiency to determine if the fetus is affected. NGS genetic testing provides a more comprehensive and efficient approach compared to traditional sequencing methods, as it allows for the analysis of multiple genes simultaneously. This can help in identifying other genetic variations or mutations that may contribute to the development of LCHAD deficiency or other related conditions. |
